
Undefeated heavyweight Moses Itauma (13-0, 11 KOs) has provided the medical specifics regarding the bicep injury that derailed his January 24 headliner against Jermaine Franklin.
Moses Itauma (13-0, 11 KOs) officially withdrew from his January 24 headline slot against Jermaine Franklin (23-2, 15 KOs) after medical scans confirmed a grade two bicep tear. The 20-year-old heavyweight prospect was forced to abandon the original Manchester date just six days before the opening bell. This specific muscle damage occurred during a high-intensity sparring session, resulting in a complete cessation of upper-body training for several weeks. The contest has now been formally rescheduled for March 28 at the same venue, marking a 63-day delay from the initial program.
During the final stages of his January camp, the southpaw felt a sharp sensation in his arm while landing a punch. Despite the immediate discomfort, the fighter initially dismissed the incident as a minor strain, attempting to resume his routine the following morning. However, a subsequent session in the ring proved the ailment was structural rather than superficial. Promoter Frank Warren mandated a diagnostic scan after observing the athlete's inability to fully extend his lead arm during technical drills. The resulting imaging showed a partial rupture of the bicep tendon, a condition that typically requires six to eight weeks of specialized rehabilitation.
This medical setback has extended Itauma's period of inactivity to over seven months, with his last professional appearance occurring in August 2024. The grade two classification indicates that the muscle fibers were significantly stretched and partially torn, though not completely detached from the bone. Such injuries severely limit a boxer's ability to generate torque or absorb impact on the affected limb. Medical staff prohibited the 13-0 fighter from even performing cardiovascular running during the acute phase of healing to prevent blood pressure spikes from aggravating the internal bleeding within the muscle tissue.
Recovery protocols involved a strict regimen of physical therapy and localized ultrasound treatment to stimulate fiber repair. Itauma has since transitioned back into live contact work, confirming that he has resumed full-power sparring as of late February. The heavyweight noted that the forced hiatus allowed for a total reset of his physical conditioning, though it disrupted the momentum of a career that boasts an 84% knockout ratio. Franklin, the 31-year-old opponent from Michigan, remains the designated challenger for the new March date, bringing a height of 6'2" and a reach of 77 inches to the encounter.
Statistical analysis of Itauma's trajectory shows he has completed only 25 total rounds across 13 professional bouts, averaging less than two rounds per contest. The bicep issue represents the first significant orthopedic hurdle of his young career, testing the durability of a frame that has largely gone untested by extended distance fights. By the time he enters the ring on March 28, the Brit will have navigated a 210-day gap between competitive appearances. This duration is the longest stretch of dormancy since he turned professional in early 2023, surpassing his previous longest break of four months.
Frank Warren’s decision to postpone rather than replace the opponent ensures that the quality of the matchup remains intact for the Manchester audience. Jermaine Franklin represents a significant escalation in difficulty, having previously taken former champions to the scorecards over twelve rounds. The American’s durability—having never been stopped in 25 professional outings—means Itauma’s repaired bicep will likely be subjected to its most rigorous mechanical stress test to date. The March event will retain the original supporting card, ensuring the logistical framework of the promotion remains consistent despite the two-month shift.
Itauma’s camp has emphasized that the healing process was monitored by independent specialists to ensure no long-term scar tissue would impede his punching mechanics. The grade two tear required a delicate balance of rest and progressive loading to ensure the tendon regained its tensile strength. Now that the fighter is cleared for competition, the focus shifts to the tactical requirements of facing a veteran who has shared the ring with Anthony Joshua and Dillian Whyte. The 20-year-old must prove that the injury has not diminished the explosive hand speed that resulted in eight first-round finishes.
The heavyweight division’s landscape continues to shift while Itauma rehabilitates, making the March 28 return a pivotal moment for his world ranking aspirations. Currently positioned as a top-tier prospect by major sanctioning bodies, the Kent-based boxer cannot afford further delays if he intends to break the record for the youngest heavyweight champion. The upcoming clash serves as a litmus test for both his physical recovery and his ability to handle the pressure of a rescheduled main event. Fans holding tickets for the January date have been informed that their entries remain valid for the new spring schedule.
Final medical clearance was granted after the fighter demonstrated full range of motion and the ability to withstand maximum resistance during eccentric loading tests. The bicep, crucial for both the hook and the uppercut, is now reportedly at 100% capacity. As the March 28 date approaches, the focus remains on whether the layoff will result in ring rust or if the forced rest has provided a necessary period of growth for the young heavyweight. The boxing world awaits to see if the 11-KO streak continues against a durable American foe who has historically proven difficult to drop.
MORE IN BOXING

Jai Opetaia Dominates Brandon Glanton to Secure Zuffa World Cruiserweight Belt

Inoue and Nakatani Set May 2 Date for Undisputed 122-Pound Championship

UFC Champion Tom Aspinall Signs with Eddie Hearn’s Matchroom Talent Agency

Jai Opetaia Targets Undisputed Cruiserweight Status in Zuffa Debut

Jai Opetaia Targets Fifth Straight KO in Zuffa Boxing Debut
YOU MIGHT ALSO LIKE
COMMENTS (0)
Sign in to join the discussion
Sign In
